002370 Zhejiang Yatai Pharmaceutical
- 3.27
- -0.04-1.21%
Zhejiang Yatai Pharmaceutical News
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward correction in the conversion price of AsiaPharma Pharmaceuticals debt
Asia Pacific Pharmaceutical: Zhejiang Asia Pacific Pharmaceutical Co., Ltd. publicly issued convertible corporate bonds tracking rating report
Asia Pacific Pharmaceuticals: Convertible Corporate Bonds 2022 Interest Payment Notice
Asia Pacific Pharmaceuticals: 2021 Interest Payment Announcement on Convertible Corporate Bonds
Asia Pacific Pharmaceuticals: 2020 Interest Payment Announcement on Convertible Corporate Bonds
Asia Pacific Pharmaceuticals: New Century Ratings Announcement on Adjusting the Company's Rating Outlook
Asia Pacific Pharmaceuticals: Announcement on the tracking rating results of convertible corporate bonds
Asia Pacific Pharmaceutical: Anxin Securities Co., Ltd.'s listing sponsorship letter for the company's public offering of convertible corporate bonds
Asia Pacific Pharmaceuticals: Credit Rating Report on Publicly Issued Convertible Corporate Bonds
Asia Pacific Pharmaceutical: Letter of Sponsorship from Anxin Securities Co., Ltd. relating to the company's public offering of convertible corporate bonds
Asia Pacific Pharmaceutical: Guohao Lawyers (Hangzhou) Firm's Supplementary Legal Opinion on the Company's Public Issuance of Convertible Corporate Bonds (1)
Asia Pacific Pharmaceutical: Legal opinion of Guohao Law Firm (Hangzhou) on the company's public issuance of convertible corporate bonds
Asia Pacific Pharmaceuticals: Online Roadshow Announcement on Public Issuance of Convertible Corporate Bonds
Asia Pacific Pharmaceuticals: Response to issues relating to the company's notification letter on the public offering of convertible corporate bonds
Asia Pacific Pharmaceuticals: Response to Feedback on the Company's Public Issuance of Convertible Corporate Bonds Application Documents (Revised Draft)
Analysis
Price Target
No Data
No Data